BRIEF published on 02/17/2025 at 10:05, 1 year 1 month ago Sartorius Releases 2024 Annual Report Financial Performance Life Sciences Sartorius Annual Report 2024 Bioprocess Solutions
PRESS RELEASE published on 02/17/2025 at 10:00, 1 year 1 month ago Sartorius releases Annual Report for 2024 Sartorius releases Annual Report for 2024. The life science company showcases financial performance and future outlook. For more details, visit the provided link Financial Performance Annual Report Sartorius 2024 Life Science
BRIEF published on 02/07/2025 at 15:53, 1 year 1 month ago Sartorius AG Proposes Dividend for 2024 Annual General Meeting Financial News Dividend Proposal Sartorius AG 2024 Fiscal Year
PRESS RELEASE published on 02/07/2025 at 15:48, 1 year 1 month ago The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share for fiscal 2024. Dividend payment on April 1, 2025 Annual General Meeting Dividend Supervisory Board Sartorius AG Preference Share
BRIEF published on 01/28/2025 at 07:05, 1 year 1 month ago Sartorius Reports Positive Closing for Fiscal 2024 Fiscal 2024 Sales Revenue Sartorius AG Growth Forecast Profit Margin
PRESS RELEASE published on 01/28/2025 at 07:00, 1 year 1 month ago Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved Sartorius closes fiscal 2024 with stable sales revenue and positive trend, meeting full-year guidance. Order intake up; cautiously optimistic outlook for 2025 Fiscal 2024 Sartorius Sales Revenue Full-year Guidance Outlook 2025
BRIEF published on 12/06/2024 at 18:26, 1 year 3 months ago Michael Grosse Appointed as New CEO of Sartorius AG CEO Transition Sartorius AG Biopharma Industry Joachim Kreuzburg Michael Grosse
BRIEF published on 12/06/2024 at 18:22, 1 year 3 months ago Michael Grosse Appointed as CEO of Sartorius AG CEO Appointment Leadership Transition Sartorius AG Biopharmaceutical Industry Michael Grosse
PRESS RELEASE published on 12/06/2024 at 18:21, 1 year 3 months ago Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG Michael Grosse appointed as CEO of Sartorius AG, succeeding Joachim Kreuzburg. Transition effective July 1, 2025. Company praises Kreuzburg's leadership and Grosse's qualifications Sartorius AG Leadership CEO Succession Joachim Kreuzburg Michael Grosse
PRESS RELEASE published on 12/06/2024 at 18:17, 1 year 3 months ago EQS-Adhoc: SARTORIUS AG: Michael Grosse to become Chief Executive Officer of Sartorius AG SARTORIUS AG appoints Dr. Michael Grosse as Chief Executive Officer, effective July 1, 2025, succeeding Dr. Joachim Kreuzburg Supervisory Board Appointment Chief Executive Officer Sartorius AG Dr. Michael Grosse
Published on 03/26/2026 at 08:05, 1 hour 4 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 4 hours 14 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 8 hours 29 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 8 hours 39 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 13 hours 54 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/26/2026 at 08:20, 49 minutes ago Eurobattery Minerals initiates comprehensive metallurgical testwork with SLR for the San Juan tungsten project
Published on 03/26/2026 at 08:00, 1 hour 8 minutes ago PNE AG closes the 2025 financial year with successful operational performance and focuses on core markets and profitability
Published on 03/26/2026 at 08:00, 1 hour 8 minutes ago Appointment and Retirement of Non-Executive Directors
Published on 03/26/2026 at 08:00, 1 hour 9 minutes ago CANCOM SE: CANCOM confirms preliminary figures; 2026 forecast published
Published on 03/26/2026 at 07:30, 1 hour 39 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 14 hours 38 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 15 hours 24 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
